High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection-Reference-Cited by-同舟云学术

High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection

Published:2021-12-31 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Mille B.¹,Ingen‐Housz‐Oro S.²³^ORCID,Prost N.⁴,Voiriot G.⁵,Soria A.⁶⁷,Tetart F.⁸,Bernier C.⁹,Morice C.¹⁰,Staumont‐Salle D.¹¹¹,Dezoteux F.¹¹¹^ORCID,

Affiliation:

1. CHU Lille Service de Dermatologie Lille France

2. AP‐HP Hôpital Henri Mondor Service de Dermatologie Créteil France

3. Univ. Paris Est Créteil Epiderme Créteil France

4. AP‐HP Hôpital Henri Mondor Service de Réanimation Créteil France

5. AP‐HP Hôpital Tenon Sorbonne Université Service de Médecine Intensive Réanimation Paris France

6. AP‐HP Hôpital Tenon Service de Dermatologie et d’Allergologie Paris HUEP Paris France

7. Centre d’immunologie et des Maladies Infectieuses – Paris (Cimi‐Paris) INSERM U1135 Paris France

8. CHU Rouen Centre Erik Satie Service de Dermatologie Rouen France

9. CHU Nantes Service de Dermatologie Nantes France

10. CHU Caen Service de Dermatologie Caen France

11. Univ. Lille CHU Lille INSERM 1286 INFINITE ‐ Institute for Translational Research in Inflammation Lille France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17885

Reference10 articles.

1. Dermatologic manifestations and complications of COVID-19

2. DRESS syndrome

3. Treating COVID-19: Review of Drug Hypersensitivity Reactions

4. Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era

5. Eosinopenia and COVID-19

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acetazolamide/voriconazole;Reactions Weekly;2022-09-03